

Meet Our Edmonton Team
The Edmonton S2BN Chapter partners with regional stakeholders to organize career development and networking events for STEM and Health/Life Sciences graduate trainees. Our aim is to support the growth of Alberta's Health and Life Sciences sector by preparing highly qualified personnel for a career path outside of academia.
Interested in joining the team? Fill out this form to let us know.

Nadia Daniel
President
PhD Candidate
Nadia joined S2BN to apply her event planning skills to bridge the gap between academia and industry. Nadia is a Ph.D. student in the Department of Medicine at the University of Alberta. Her research focuses on understanding the basic mechanisms underlying the development of allergic diseases. The main focus is the role of barrier function in airway epithelial cells using in vitro and ex vivo human models. Her research will improve our understanding of the fundamental mechanisms of the barrier function in the airway epithelium.

Gina Sykes
Event Coordinator
PhD Student
Gina is completing her degree with the Department of Medicine at the University of Alberta. She is researching the acute immune response to ischemic stroke in the blood of stroke patients using gene expression and metabolite analysis.



Quinten Kieser
Outreach Coordinator
PhD Candidate
Quinten is completing his degree through the Department of Medical Microbiology and Immunology. His research focuses on understanding the entry mechanism used by respiratory syncytial virus in hopes of identifying new therapeutic targets.



Alberto Felix-Lopez
Communications Coordinator
PhD Candidate
Alberto is currently a PhD Candidate in the Medical Microbiology and Immunology (MMI) department at UofA. His research focuses on identifying host dependency factors essential for SARS-CoV-2 infection that can be disturbed by FDA approved drugs.


Jay Gamma
Treasurer
PhD Candidate
Jay is an PhD Candidate in the Department of Medicine at the University of Alberta. His research is exploring the importance of myristoylation in Acute Myeloid Leukemia, and assess the efficacy and functionality of Pacylex Pharmaceutical's drug candidate PCLX-001 as a novel, first-in-class treatment for AML and related cancers.

Kevin Joannou
Event Coordinator
PhD Candidate
Kevin is a graduate student in the Medical Microbiology and Immunology department at the University of Alberta.


Shae is doing research with the Department of Medical Microbiology and Immunology at the University of Alberta.
Shae Komant
Event Coordinator
PhD Student
